Characterization of Renal Allograft Rejection by Urinary Proteomic Analysis

ObjectiveTo develop a diagnostic method with no morbidity or mortality for the detection of acute renal transplant rejection. Summary Background DataRejection constitutes the major impediment to the success of transplantation. Currently available methods, including clinical presentation and biochemical organ function parameters, often fail to detect rejection until late stages of progression. Renal biopsies have associated morbidity and mortality and provide only a limited sample of the organ. MethodsThirty-four urine samples were collected from 32 renal transplant patients at various stages posttransplantation. Samples were collected from 17 transplant recipients with acute rejection and 15 patients with no rejection. Samples from patients less than 4 days posttransplant were omitted from data analysis due to the presence of excessive inflammatory response proteins. Rejection status was confirmed by kidney biopsy. Specimens were analyzed in triplicate using SELDI mass spectrometry. The obtained spectra were subjected to bioinformatic analysis using ProPeak as well as CART (Classification and Regression Tree) algorithms to identify rejection biomarker candidates. These candidates were identified by their molecular weight and ranked by their ability to distinguish between nonrejection and rejection based on receiver operating characteristic (ROC) analysis. The candidates with the highest area under the ROC curve (AUC) exhibited the best diagnostic performance. ResultsThe best candidate biomarkers demonstrated highly successful diagnostic performance: 6.5 kd (AUC = 0.839, P < .0001), 6.7 kd (AUC = 0.839, P < .0001), 6.6 kd (AUC = 0.807, P < .0001), 7.1 kd (AUC = 0.807, P < .0001), and 13.4 kd (AUC = 0.804, P < .0001). A separate analysis using the CART algorithm in the Ciphergen Biomarker Pattern Software correctly classified 91% of the 34 specimens in the training set, giving a sensitivity of 83% and specificity of 100% using two separate biomarker candidates at 10.0 kd and 3.4 kd. ConclusionsBiomarker candidates exist in urine that have the ability to distinguish between renal transplant patients with no rejection and those with acute rejection. These biomarker candidates are the basis for development of a noninvasive method of diagnosing acute rejection without the morbidity and mortality associated with needle biopsy. The combination of biomarkers into a panel for diagnosis leads to the possibility of enhanced diagnostic performance.

[1]  Kimberly F. Johnson,et al.  Methods of microarray data analysis : papers from CAMDA , 2002 .

[2]  S. Ohlman,et al.  THE IMPACT OF ACUTE REJECTION EPISODES ON LONG‐TERM GRAFT FUNCTION AND OUTCOME IN 1347 PRIMARY RENAL TRANSPLANTS TREATED BY 3 CYCLOSPORINE REGIMENS , 1993, Transplantation.

[3]  Zhen Zhang,et al.  Applying Classification Separability Analysis to Microarray Data , 2002 .

[4]  D. Stablein,et al.  Safety of kidney biopsy in pediatric transplantation: a report of the Controlled Clinical Trials in Pediatric Transplantation Trial of Induction Therapy Study Group. , 1999, Transplantation.

[5]  M. Nicholson,et al.  Analysis of factors associated with complications following renal transplant needle core biopsy. , 1994, British journal of urology.

[6]  D. Leehey,et al.  Improved graft survival after renal transplantation in the United States, 1988 to 1996. , 2000, The New England journal of medicine.

[7]  A. Gaber,et al.  Correlation of histology to clinical rejection reversal: a thymoglobulin multicenter trial report. , 1999, Kidney international.

[8]  P. Belitsky,et al.  THE INCIDENCE AND IMPACT OF EARLY REJECTION EPISODES ON GRAFT OUTCOME IN RECIPIENTS OF FIRST CADAVER KIDNEY TRANSPLANTS , 1992, Transplantation.

[9]  D. Chan,et al.  Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. , 2002, Clinical chemistry.

[10]  Vladimir Vapnik,et al.  Statistical learning theory , 1998 .

[11]  P. Nickerson,et al.  The urine protein to creatinine ratio (P/C) as a predictor of 24-hour urine protein excretion in renal transplant patients. , 2001, Transplantation.

[12]  C. Cardella,et al.  Percutaneous needle biopsy of the transplanted kidney: technique and complications. , 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  M. Suthanthiran,et al.  Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. , 2001, The New England journal of medicine.

[14]  J. Sorof,et al.  HISTOPATHOLOGICAL CONCORDANCE OF PAIRED RENAL ALLOGRAFT BIOPSY CORES: EFFECT ON THE DIAGNOSIS AND MANAGEMENT OF ACUTE REJECTION , 1995, Transplantation.

[15]  J. Lemann,et al.  Proteinuria in health and disease assessed by measuring the urinary protein/creatinine ratio. , 1987, Clinical chemistry.

[16]  S. Hariharan,et al.  Improved graft survival after renal transplantation in the United States, 1988 to 1996. , 2000, The New England journal of medicine.

[17]  J. Cecka.  The UNOS Scientific Renal Transplant Registry. , 1999, Clinical transplants.

[18]  E. Woodle,et al.  Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies. , 1996, Transplantation.

[19]  T. Yip,et al.  Bactericidal domain of lactoferrin: detection, quantitation, and characterization of lactoferricin in serum by SELDI affinity mass spectrometry. , 1998, Biochemical and biophysical research communications.

[20]  D. Rush,et al.  Histological findings in early routine biopsies of stable renal allograft recipients. , 1994, Transplantation.

[21]  R. Cox,et al.  DNA concentrations in serum and plasma. , 1977, Clinical chemistry.

[22]  D. Dunn,et al.  Risk factors for chronic rejection in renal allograft recipients. , 1993, Transplantation.

[23]  T. Yamaguchi,et al.  [Clinical evaluation of the albumin/creatinine ratio in outpatients with diabetes]. , 1991, Nihon Jinzo Gakkai shi.

[24]  B. Julian,et al.  Dilemmas in renal transplantation: when the clinical course and histological findings differ. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  E. Fung,et al.  Proteomic approaches to tumor marker discovery. , 2002, Archives of pathology & laboratory medicine.

[26]  Cecka Jm.  The UNOS Scientific Renal Transplant Registry. , 1999 .

[27]  J. Pirsch,et al.  Long-term efficacy and safety of cyclosporine in renal-transplant recipients. , 1994, The New England journal of medicine.

[28]  I. Roberti,et al.  SERIAL EVALUATION OF CELL SURFACE MARKERS FOR IMMUNE ACTIVATION AFTER ACUTE RENAL ALLOGRAFT REJECTION BY URINE FLOW CYTOMETRY: Correlation with Clinical Outcome1 , 2001, Transplantation.